News
Researchers uncover corneal changes in multiple myeloma patients treated with belantamab mafodotin, revealing potential ...
Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...
Q1 2025 Earnings Conference Call May 9, 2025 10:00 AM ETCompany ParticipantsJustine Koenigsberg - Vice President ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback